Mentor Capital Gains 4,000 Shareholders During First Quarter

Cannabis M&A Leader Provides Public Market Based Liquidity and Cash for Larger Medical Marijuana Operators

SAN DIEGO--()--Mentor Capital, Inc. (OTCQB: MNTR) announced it has continued adding over 1,000 shareholders per month bringing its base of active shareholders who have Mentor shares in a brokerage account to 10,000 from 6,000 just at year end and 3,000 only three months earlier. “This extraordinary strong shareholder base allows Mentor to provide an avenue for larger independently operated cannabis company founders and investors to achieve liquidity for their growing business value by working with Mentor,” comments Mentor Capital, Inc. CEO, Chet Billingsley.

“Mentor Capital’s larger cannabis actions in the last four months include an initial $1.0 million investment in G Farma, purchase of $1.0 million in GW Pharmaceuticals (GWPH) shares, being awarded a $1.9 million judgment against Bhang Corporation, and after making the marijuana related investments bringing our current cash position back to $1.9 million. In addition to its cash, the company holds an investment annuity that calculates to pay Mentor $1.0 million and has illiquid legacy assets that generate $2.7 million in sales. Upon the event of a private sale, the proceeds of the legacy assets together with the annuity payout are also targeted to additional cannabis investment,” summarizes CEO Billingsley.

About Mentor Capital: The Company seeks to come alongside and assist private medical marijuana and cannabis companies and their founders in meeting their liquidity and financial objectives, to add protection for investors and to help incubate private cannabis companies. Additional important information for investors is presented at: www.MentorCapital.com.

This press release is neither an offer to sell, nor a solicitation of offers to purchase, securities.

Forward Looking Statements: This press release contains forward-looking statements within the meaning of the federal securities laws, including statements concerning financial projections, financing activities, corporate combinations, product development activities and sales and licensing activities. Such forward-looking statements are not guarantees of future results or performance, are sometimes identified by words of condition such as “should,” “could,” “expects,” “may,” “intends,” “seeks,” “looks,” “moves,” or “plans” and are subject to a number of risks and uncertainties, known and unknown, that could cause actual results to differ materially from those intended or anticipated. Such risks include, without limitation: nonperformance of investments, partner and portfolio difficulties, potential delays in marketing and sales, problems securing the necessary financing to continue operations, problems involving continued illegality of cannabis products, potential of competitive products, services, and technologies, difficulties experienced in product development, in recruiting knowledgeable personnel, in collecting judgments and in protecting intellectual property. Further information concerning these and other risks is included in the Company’s Form 10-K and 10-Q filings which, along with other very important information about the Company, can be found here:

http://mentorcapital.com/disclosures/

The Company undertakes no obligation to update or revise such forward-looking statements to reflect new information, events or circumstances occurring after the date of this press release.

Contacts

Mentor Capital, Inc.
Chet Billingsley, CEO
(760) 788-4700

Release Summary

Mentor Capital (MNTR) added 4,000 shareholders during the first quarter bringing its investor base to 10,000. MNTR invested $1M in GFarma, $1M in GWPH, with $5.6M in other holdings & $1.9M cash.

Contacts

Mentor Capital, Inc.
Chet Billingsley, CEO
(760) 788-4700